Welcome to our dedicated page for Sol Gel Tech SEC filings (Ticker: SLGL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sol-Gel Technologies Ltd.'s SEC filings document the disclosure record of a foreign private issuer developing and partnering dermatology drug products. Form 6-K reports include operating and financial results, unaudited condensed financial statements, clinical and regulatory updates for SGT-610, SGT-210 and EPSOLAY, and material-event disclosures incorporated by reference into the company's Form S-8 and Form F-3 registration statements.
The filings also cover shareholder meeting materials, auditor appointments, board elections, interim executive leadership approvals under Israeli corporate governance requirements, and capital-structure matters involving the company's ordinary shares. These documents frame Sol-Gel's public-company reporting around dermatology pipeline development, approved topical products, licensing arrangements, governance actions, and financing capacity.
Sol-Gel Technologies Ltd. had an insider ownership update involving entities managed by Opaleye Management Inc. On February 2, 2026, Opaleye, L.P. purchased 100 ordinary shares of Sol-Gel at $58 per share, bringing its indirectly held position to 450,944 ordinary shares. A separately managed account overseen by Opaleye Management holds an additional 10,000 ordinary shares indirectly. Opaleye Management Inc. states that it may be deemed to beneficially own these securities but disclaims beneficial ownership beyond its pecuniary interest.
Opaleye Management Inc., a 10% owner of Sol-Gel Technologies Ltd., reported an indirect open‑market purchase of 100 ordinary shares on January 27, 2026 at $57.05 per share. These shares are held by Opaleye, L.P., bringing that fund’s reported holdings to 449,944 shares. A separately managed account associated with Opaleye holds an additional 10,000 shares. Opaleye Management Inc. states it may be deemed to beneficially own these securities through its roles with the fund and managed account, but disclaims beneficial ownership except to the extent of its pecuniary interest.
Opaleye Management Inc., a 10% owner of Sol-Gel Technologies Ltd. (SLGL), reported January open-market share purchases made through affiliated investment vehicles. On January 22, 2026, Opaleye, L.P. bought 2,173 ordinary shares at a weighted average price of $56.5681 per share, and on January 23, 2026 it bought another 1,151 shares at a weighted average price of $55.9809. After these transactions, 449,844 ordinary shares were held indirectly through Opaleye, L.P., and an additional 10,000 shares were held indirectly via a separately managed account. The filing notes that prices reflect weighted averages across multiple trades within disclosed price ranges and that Opaleye Management Inc. disclaims beneficial ownership beyond its pecuniary interest.
SLGL security holder Itzik Yosef filed a Form 144 notice to sell 713 ordinary shares. The planned sale is to be executed through Oppenheimer & Co. Inc. on or about 01/14/2026, with an aggregate market value of $44,876.22, and the shares are listed on Nasdaq. The filing states that 27,857,620 ordinary shares were outstanding.
The 713 shares were acquired on 08/02/2016 under an employee stock option plan from the issuer, with cash payment upon option exercise dated 01/15/2026. In the past three months, the same seller has reported sales of 398, 54 and 3 ordinary shares on 01/07/2026, 01/12/2026 and 01/13/2026, for gross proceeds of $19,974.27, $3,513.01 and $195.00, respectively.
Sol-Gel Technologies Ltd. filed a Form 6-K as a foreign private issuer to furnish a press release issued on December 17, 2025. The press release provides an update following unblinding of the company’s Phase 1b study of SGT-210 in Darier Disease.
Exhibit 99.1, which contains the press release (other than its third paragraph), is incorporated by reference into Sol-Gel’s existing Registration Statements on Form S-8 (Registration Nos. 333-223915, 333-270477 and 333-286820) and its Registration Statement on Form F-3 (Registration No. 333-286822).
Opaleye Management Inc., reporting as a 10% owner of Sol-Gel Technologies Ltd., disclosed a small indirect purchase of ordinary shares. On 12/12/2025, 87 ordinary shares with a par value of NIS 1.00 per share were acquired at a reported price of $40. After this transaction, 371,795 ordinary shares are held indirectly through Opaleye, L.P. and 10,000 ordinary shares are held indirectly through a separately managed account. Opaleye Management Inc. states it may be deemed to beneficially own these securities through its roles with the fund and managed account, but disclaims beneficial ownership except to the extent of its pecuniary interest.
Opaleye Management Inc. reported open market purchases of Sol-Gel Technologies Ltd. (SLGL) ordinary shares. On 11/24/2025, an affiliated fund bought 6 ordinary shares at $35.5 per share, and on 11/26/2025 it bought another 943 shares at a weighted average price of $40.00. Following these transactions, the fund is shown as beneficially owning 364,100 Sol-Gel ordinary shares, with an additional 10,000 shares held in a separately managed account. Opaleye Management Inc. states that it may be deemed to beneficially own these securities through its roles with the fund and the managed account and disclaims beneficial ownership except to the extent of its pecuniary interest.
Sol-Gel Technologies Ltd. (SLGL) director Opaleye Management Inc. reported buying additional ordinary shares. On 11/20/2025, an affiliated fund purchased 5,784 ordinary shares at a weighted average price of $35.8305 per share in multiple trades within a price range of $35.132 to $36.10. After this transaction, Opaleye Management Inc. reports indirect beneficial ownership of 363,151 ordinary shares through Opaleye, L.P. and 10,000 ordinary shares through a separately managed account. The firm states it may be deemed to beneficially own these securities as investment manager and portfolio manager, while disclaiming beneficial ownership beyond its economic interest.
Sol-Gel Technologies Ltd. (SLGL) submitted a Form 6-K reporting that it issued a press release on November 20, 2025 announcing its financial results for the quarter ended September 30, 2025. The filing mainly serves to furnish this press release to investors.
Most of the press release, identified as Exhibit 99.1 (other than the two paragraphs immediately preceding the heading “Financial Results for the Third Quarter 2025”), is incorporated by reference into the company’s Registration Statements on Form S-8 (Registration Nos. 333-223915, 333-270477 and 333-286820) and its Registration Statement on Form F-3 (Registration No. 333-286822).
Sol-Gel Technologies Ltd. (SLGL) received an initial ownership report from Opaleye Management Inc. as a 10% owner. The filing shows indirect beneficial ownership of 357,367 ordinary shares through Opaleye, L.P. and 10,000 ordinary shares through a separately managed account. Opaleye Management Inc. states it may be deemed to beneficially own these securities as investment manager and portfolio manager, but expressly disclaims beneficial ownership beyond its economic interest.